RISK-BASED APPROACHES IN GLOBAL REGULATORY SUBMISSIONS FOR RARE DISEASES. (2023). Indo-American Journal of Pharma and Bio Sciences, 21(3), 10-20. https://iajpb.org/index.php/iajpb/article/view/172